SGMT
Sagimet Biosciences Inc.
Biotechnology · Healthcare · United States
9.92
close · 2026-10-30
value
82
cheaper than peers82
quality
94
stronger fundamentals94
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, 2 years ago | -3.4% | 80 |
| cash flow yield, latest year | -6.5% | 75 |
| cash flow yield, 3 years ago | -3.5% | 73 |
| cash flow yield, 1 year ago | -6.0% | 72 |
| earnings yield, 3 years ago | -13.9% | 71 |
| earnings yield, 1 year ago | -14.6% | 65 |
| earnings yield, latest year | -15.9% | 59 |
| earnings yield, 2 years ago | -26.8% | 58 |
| price to book | 2.39× | 52 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 0.0% | 97 |
| return on equity | -36.0% | 81 |
| operating margin | 0.0% | 50 |
3 of 4 measures available
Facts
| market cap | $703M |
| free cash flow | -$27.2M |
| employees | 16 |
| first trade | 2023-07-14 |
| next earnings | 2026-08-11 |
| fundamentals updated | 2026-08-11 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 | 2021 |
| diluted eps | -1.58 | -1.45 | -2.66 | -1.38 | not reported |
| free cash flow | -$45.6M | -$42.4M | -$23.8M | -$24.5M | not reported |
| net income | -$51.0M | -$45.6M | -$27.9M | -$30.5M | not reported |
| revenue | $0 | $0 | $2.0M | $0 | not reported |
| unusual items | not reported | not reported | $4,000 | $3,000 | -$749,000 |